What’s going on in Washington DC, and what does it mean for people with Parkinson’s?

News

Author: Parkinson's Life editorsPublished: 16 August 2017

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

Washington DC

In the US, the debate surrounding Parkinson’s care and research funding has hit Washington DC. Learn more about the US legislation that could impact people with Parkinson’s in this month’s free webinar from the Michael J Fox Foundation 


The next episode of the Michael J Fox Foundation’s Third Thursday webinar series will focus on ‘What’s going on in Washington?’ and will be broadcast on 17 August at 12:00 EST.

Regular host Dave Iverson, principal moderator for Partners in Parkinson’s, will lead the discussion on US legislation that could impact access to Parkinson’s care and research funding.

Listeners are encouraged to engage with the debate in real time to discuss these issues and what they mean for Parkinson’s community.

The Michael J Fox Foundation will also share resources that listeners will be able to use to help advocate this August, while United States Congress is in recess and lawmakers return to their home states to meet with constituents.

It’s free to join the live webinar – just register here up to 15 minutes before it starts. If you miss the live broadcast, you can catch up via the recording in the library archive here.


Read more: Drug repurposing: testing a drug approved for one disease for its efficacy in another

Young-onset Parkinson’s disease: the challenges and treatment options

Go Back

Share this story

Comments


Related articles


180221_ Dave Clark fundraising

Interviews

Dave Clark: “I’m not going to hide away”

We spoke to sports commentator Dave Clark about living with Parkinson's

READ MORE

Interviews

“The lockdown has affected people with Parkinson’s in India immensely”

Dr Maria Barretto on how Covid-19 is impacting Parkinson’s community

READ MORE

Women and Parkinson's

“We do ourselves an injustice by just suffering through it”

Richelle Flanagan on connecting with Parkinson’s disease community

READ MORE